Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance?
George Kunos, … , Tony Jourdan, Joseph Tam
George Kunos, … , Tony Jourdan, Joseph Tam
Published January 4, 2022
Citation Information: J Clin Invest. 2022;132(1):e155330. https://doi.org/10.1172/JCI155330.
View: Text | PDF
Letter to the Editor Metabolism

Download this citation for these citation managers:

Or, download this citation in these formats:

If you experience problems using these citation formats, send us feedback.
Advertisement